Form 483

Auro PR Inc. Form 483, 2023-05-31

FDA issued a Form 483 to Auro PR Inc. on 2023-05-31 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Auro PR Inc. · Caguas, United States · Issued May 31, 2023

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

31 May 2023
21 CFR 211.165(b)

Microbiological testing

Cited by Marian E Ramirez, Angelica M Hernandez, Alan A Rivera

31 May 2023
21 CFR 211.166(a)(4)

Testing in same container - closure system

Cited by Marian E Ramirez, Angelica M Hernandez, Alan A Rivera

Inspected site

APAuro PR Inc.Caguas, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(4)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 2 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere